Getinge (GETI)

Sector:

Medicine and Biotech Research

Index:

OMX Stockholm

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

Sk 101.25
   
  • 52 Week High: Sk152.56
  • 52 Week Low: Sk78.75
  • Currency: Swedish Krona
  • Shares Issued: 222.84m
  • Market Cap: Sk22,562m

Getinge Overview

Getinge AB is a Swedish manufacturer and supplier of medical technical equipment for surgery, intensive care and infection control. The company offers disinfectors and sterilizers for the hospitals and the pharmaceutical industry, documentation systems, ancillary equipment, systems for hygiene and the transfer of the elderly and disabled. Getinge AB operates in Europe, the United States, Canada, Asia and Africa. The company has its headquarter in Getinge in Halland County, Sweden.

3 Month Chart

3 Month Chart

1 Year Chart

1 Year Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover 2.9
Op Mrgn 16.6%
ROCE 46.6%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue -2.8%
PBT 18.3%
EPS 19.1%
DPS 18.2%

Getinge Fundamentals

Year Ending Revenue (Skm) Pre-tax (Skm) EPS P/E PEG EPS Grth. Div Yield
31-Dec-06 13,001.00 1,728.00 6.09Sk 24.7 2.5 +10% 2.16 1.4%
31-Dec-07 16,445.00 1,748.00 5.73Sk 29.7 n/a -6% 2.35 1.4%
31-Dec-08 19,272.00 2,126.00 7.23Sk 12.9 0.5 +26% 2.40 2.6%
31-Dec-09 22,816.00 2,634.00 8.02Sk n/a n/a +11% 2.75 0.0%
31-Dec-10 22,172.00 3,116.00 9.55Sk n/a n/a +19% 3.25 0.0%

Getinge Forecasts

Getinge Forecasts data is not available for this company.

Copyright © 2012 FactSet Research Systems Inc. All rights reserved.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are end of day values only.

Note 2: Forecast figures based on normalised accounts.

 

Getinge Market Data

Currency Swedish Krona
% Change -0.74 %
52 Week High Sk152.56
52 Week Low Sk78.75
Shares Issued 222.84m
Market Cap Sk22,562m

What The Brokers Say

Strong Buy 7
Buy 1
Neutral 6
Sell 2
Strong Sell 2
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Top of Page